Evidence map›Paper›PMID 34235359›Full record

ArticleJournal of the Endocrine Society2021

Novel Gene Mutations Regulating Immune Responses in Autoimmune Polyglandular Syndrome With an Atypical Course.

Marina Yukina, Taisia Erofeeva, Nurana Nuralieva, Tatiana Andreeva, Elena Savvateeva, Natalia Dudko, Ekaterina Troshina, Evgeny Rogaev, Galina Melnichenko

Open access · goldAbstract read
In one paragraph

Article in Journal of the Endocrine Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Marina YukinaEndocrinology Research Centre, Moscow 117036, Russia.ORCID https://orcid.org/0000-0002-8771-8300
Taisia ErofeevaLaboratory of Evolutionary genomics, Department of Genomics and Human Genetics, Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow 119333, Russia.
Nurana NuralievaEndocrinology Research Centre, Moscow 117036, Russia.
Tatiana AndreevaLaboratory of Evolutionary genomics, Department of Genomics and Human Genetics, Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow 119333, Russia.
Elena SavvateevaCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow 119991, Russia.
Natalia DudkoLaboratory of Evolutionary genomics, Department of Genomics and Human Genetics, Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow 119333, Russia.
Ekaterina TroshinaEndocrinology Research Centre, Moscow 117036, Russia.
Evgeny RogaevLaboratory of Evolutionary genomics, Department of Genomics and Human Genetics, Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow 119333, Russia.
Galina MelnichenkoEndocrinology Research Centre, Moscow 117036, Russia.
Endocrinology Research Center · RUVavilov Institute of General Genetics · RUEngelhardt Institute of Molecular Biology · RULomonosov Moscow State University · RUUniversity of Massachusetts Chan Medical School · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextAutoimmune polyglandular syndrome (APS) is a cluster of endocrine disorders arising from immune dysregulation, often combined with damage to nonendocrine organs. There are 2 types of APS: type 1 and type 2 (APS-1 and APS-2, respectively). In clinical practice, an atypical course of APS is often observed.

objectiveThis work aims to find a novel genetic predictor of APS.

methodsWe performed exome sequencing in 2 patients with an atypical clinical APS picture and members of their families. Patient A presented with a manifestation of APS-2 in early childhood and patient B with a late manifestation of the main components of APS-1.

resultsIn patient B, we identified inherited compound mutations as a novel combination of the

conclusionOur data revealed novel combination of mutations in the

Indexed as

atypical courseautoimmune polyglandular syndromeearly manifestationexome sequencinggenetic predictors

Identifiers

PMID34235359
PMCPMC8252644
OpenAlexW3159866685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.